Neurology Positioned To Benefit From Progress In Regenerativ

Diseases and injuries that affect central nervous system neurons are among the illnesses that are hardest to cure. Their frequency increases dramatically with age, and morbidity associated with neurological disorders is expected to rise dramatically in the coming years in lockstep with the aging of the population. Evidence that neurogenesis persists beyond the embryonic and early developmental periods has led to a number of programs in academia and the commercial sector that seek to stimulate the differentiation and growth of adult neural stem cells.

A number of small companies are focusing on the development of methods and tools to enhance the regenerative responses of axons following different kinds of acute insults or chronic damage resulting from neurological conditions. Advances in neurogenesis and nerve regeneration are being chaperoned by a number of enabling technologies such as functional mapping, which is already being used in a number of clinical settings, and enhanced diagnostic imaging. These developments will accelerate the pace of clinical successes in a segment with significant market potential.

These findings are contained in a new and comprehensive report. Neurogenesis and Nerve Regeneration contains detailed and insightful analysis of programs, participants and prospects in this evolving sector.

About Greystone

Greystone Associates is a medical and healthcare technology consulting firm providing services in strategic planning, venture development, product commercialization, and technology and market assessment.

http://www.greystoneassociates.org .
(责任编辑：泉水)

搜索

热门标签:

Neurology Positioned To Benefit From Progress In Regenerativ